HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
Market capitalization of HTG Molecular Diagnostics (HTGM)
Market cap: $1.06 Million
As of April 2024 HTG Molecular Diagnostics has a market cap of $1.06 Million. This makes HTG Molecular Diagnostics the world's 8329th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of HTG Molecular Diagnostics from 2015 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.06 M | 0% |
| 2023 | $1.06 M | -73.96% |
| 2022 | $4.08 M | -90.05% |
| 2021 | $41.01 M | 80.67% |
| 2020 | $22.7 M | -44.32% |
| 2019 | $40.77 M | -43.84% |
| 2018 | $72.6 M | 185.97% |
| 2017 | $25.38 M | 60.43% |
| 2016 | $15.82 M | -46.96% |
| 2015 | $29.84 M |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.40 B | 38,127.28% | 🇺🇸 USA |
 Affimed
AFMD | $78.42 M | 7,278.57% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | $0.12 M | -88.52% | 🇺🇸 USA |